{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:43:22Z","timestamp":1773265402217,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) is a common cause of secondary hypertension, yet its diagnosis in young and middle-aged adults remains challenging due to low screening rates and complex testing procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate serum polyunsaturated fatty acid (PUFA) profiles, particularly the docosapentaenoic acid\/arachidonic acid (DPA\/AA) ratio, as novel biomarkers of PA in young adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This 1:1 matched case\u2013control study was performed on 138 young and middle-aged patients with PA and 138 essential hypertension (EH) controls. Serum PUFA levels were measured, and their associations with PA were analyzed using univariate and multivariate logistic regression analyses. Using bootstrap to conduct internal validation. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were employed to evaluate both the predictive performance and clinical practicability of the model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Young and middle-aged patients with PA exhibited a distinct phenotype, including more severe hypertension, higher fasting blood glucose level, elevated low-density lipoprotein-cholesterol level, lower platelet count, and greater burden of left ventricular hypertrophy and albuminuria. A significantly reduced DPA\/AA ratio was the most notable finding in the PA group. The multivariate analysis revealed DPA\/AA as a strong independent inverse predictor of PA. Adding DPA\/AA to a baseline model of traditional clinical and biochemical variables increased the area under the curve (AUC) from 0.849 to 0.866. The integration into a more comprehensive model also improved the AUC from 0.872 to 0.887.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The DPA\/AA ratio is a robust, independent biomarker of PA in young and middle-aged adults. Its incorporation into diagnostic models significantly enhances predictive accuracy, thus offering a promising noninvasive approach to improve early detection in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1771955","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:37:24Z","timestamp":1773207444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["DPA\/AA ratio as a potential biomarker of primary aldosteronism in young and middle-aged adults"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenli","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runlong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","article-title":"Primary aldosteronism: where are we now? Where to from here","volume":"79","author":"Funder","year":"2022","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.529","article-title":"Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events","volume":"74","author":"Zhang","year":"2019","journal-title":"J Of Am Coll Of Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1038\/s41598-025-92477-9","article-title":"The association between aldosterone and lipid profiles in patients with primary aldosteronism","volume":"15","author":"Liang","year":"2025","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients","volume":"30","author":"Colussi","year":"2007","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1055\/s-0030-1261966","article-title":"Primary aldosteronism and diabetes mellitus","volume":"42","author":"Steichen","year":"2010","journal-title":"Horm Metab Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0272049","DOI":"10.1371\/journal.pone.0272049","article-title":"Clinical and biochemical predictors and predictive model of primary aldosteronism","volume":"17","author":"Manosroi","year":"2022","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40292-016-0135-6","article-title":"Association between lifestyle and systemic arterial hypertension in young adults: A national, survey-based, cross-sectional study","volume":"23","author":"Bruno","year":"2016","journal-title":"High Blood Pressure Cardiovasc Prev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: An update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833266e3","article-title":"Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism","volume":"28","author":"Pizzolo","year":"2010","journal-title":"J Hypertens"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab047","article-title":"Adrenal venous sampling in young patients with primary aldosteronism. Extravagance or irreplaceable","volume":"106","author":"Gkaniatsa","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)60445-x","article-title":"Cardiovascular effects of marine omega-3 fatty acids","author":"Saravanan","year":"9740","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200208000-00010","article-title":"Blood pressure response to fish oil supplementation: Metaregression analysis of randomized trials","volume":"20","author":"Geleijnse","year":"2002","journal-title":"J Of Hypertens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.2.523","article-title":"Does fish oil lower blood pressure? A meta-analysis of controlled trials","volume":"88","author":"Morris","year":"1993","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-511X-7-37","article-title":"Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules","volume":"7","author":"Das","year":"2008","journal-title":"Lipids Health Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"111836","DOI":"10.1016\/j.mce.2022.111836","article-title":"Fatty acids as a direct regulator of aldosterone hypersecretion","volume":"561","author":"Ling","year":"2023","journal-title":"Mol And Cell Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1410154","article-title":"Associations of \u03c9-3, \u03c9-6 polyunsaturated fatty acids intake and \u03c9-6: \u03c9-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020","volume":"11","author":"Li","year":"2024","journal-title":"Front Nutr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2015.1126549","article-title":"Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome","volume":"57","author":"Tortosa-Caparr\u00f3s","year":"2017","journal-title":"Crit Rev In Food Sci And Nutr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.05.007","article-title":"The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies","volume":"262","author":"Harris","year":"2017","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101559","article-title":"Uncommon fatty acids and cardiometabolic health","volume":"10","author":"Li","year":"2018","journal-title":"Nutrients"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.10.038","article-title":"Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects","volume":"792","author":"Khaddaj-Mallat","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5650\/jos.ess17111","article-title":"Docosapentaenoic acid (22:5n-3) downregulates mRNA expression of pro-inflammatory factors in LPS-activated murine macrophage like RAW264.7 Cells","volume":"66","author":"Tian","year":"2017","journal-title":"J Oleo Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.2925","article-title":"Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies","volume":"176","author":"Del Gobbo","year":"2016","journal-title":"JAMA Internal Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/lite.201500013","article-title":"Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid","volume":"27","author":"Byelashov","year":"2015","journal-title":"Lipid Technol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.1012","article-title":"Lipid profiles in primary aldosteronism compared with essential hypertension: propensity-score matching study","volume":"36","author":"Moon","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","article-title":"2018 chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of chinese guidelines for prevention and treatment of hypertension","volume":"16","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn311282-20200615-00444","article-title":"Expert consensus on the diagnosis and treatment of primary aldosteronism (2020)","volume":"36","year":"2020","journal-title":"Chin J Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1019058","article-title":"Association between the ratio of serum eicosapentaenoic acid to arachidonic acid and risk of coronary artery disease in young Chinese patients","volume":"9","author":"Liu","year":"2022","journal-title":"Front Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112148-20240102-00002","article-title":"Chinese guideline for lipid management (primary care version 2024)","volume":"52","year":"2024","journal-title":"Chin J Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3760\/cma.j.cn115791-20241203-00705","article-title":"Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)","volume":"17","year":"2025","journal-title":"Chin J Diabetes Mellitus"},{"key":"B33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12290\/xhyxzz.2024-0918","article-title":"Chinese guidelines for the clinical management of obesity (2024 edition)","volume":"16","year":"2025","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.04.156","article-title":"Mean platelet volume in patients with primary aldosteronism and its relation to left ventricular hypertrophy","volume":"168","author":"Kurisu","year":"2013","journal-title":"Int J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz306","article-title":"Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism","volume":"105","author":"Charlotte","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1038\/s41598-023-50677-1","article-title":"Apela promotes blood vessel regeneration and remodeling in zebrafish","volume":"14","author":"Nys","year":"2024","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16626","DOI":"10.1038\/s41598-020-73638-4","article-title":"The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial","volume":"10","author":"Minakuchi","year":"2020","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac408","article-title":"Histopathology and genetic causes of primary aldosteronism in young adults","volume":"107","author":"Nanba","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/nu15122672","article-title":"The effects of omega 3 and omega 6 fatty acids on glucose metabolism: An updated review","volume":"15","author":"Egalini","year":"2023","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"B45","doi-asserted-by":"publisher","first-page":"103577","DOI":"10.1016\/j.sjbs.2023.103577","article-title":"Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia","volume":"30","author":"Alfhili","year":"2023","journal-title":"Saudi J Biol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600360R","article-title":"Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid","volume":"30","author":"Markworth","year":"2016","journal-title":"FASEB J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.tem.2024.12.001","article-title":"Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism","volume":"36","author":"Wu","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-025-02211-1","article-title":"Fatty acid profiles in aldosterone-producing adenoma: Insights into pathogenetic significance","volume":"48","author":"Murakami","year":"2025","journal-title":"Hypertens Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00394-012-0396-3","article-title":"A short-term n-3 DPA supplementation study in humans","volume":"52","author":"Miller","year":"2013","journal-title":"Eur J Of Nutr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2013.01.010","article-title":"Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans","volume":"88","author":"Linderborg","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.1111\/1462-2920.70090","article-title":"Genetic analysis of polyunsaturated fatty acids biosynthesis pathway determines four distinct thraustochytrid types","volume":"27","author":"Cheng","year":"2025","journal-title":"Environ Microbiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36368","DOI":"10.1038\/srep36368","article-title":"Omega-3 and omega-6 DPA equally inhibit the sphingosylphosphorylcholine-induced Ca(2+)-sensitization of vascular smooth muscle contraction via inhibiting Rho-kinase activation and translocation","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00814.2013","article-title":"Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension","volume":"307","author":"Morin","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019949","article-title":"Effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: the OMEGA-REMODEL randomized clinical trial","volume":"134","author":"Heydari","year":"2016","journal-title":"Circulation"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1771955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:37:30Z","timestamp":1773207450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1771955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":54,"alternative-id":["10.3389\/fendo.2026.1771955"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1771955","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1771955"}}